These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28104239)

  • 1. CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Vignesh R; Krishnan J; Sigamani P; Saeidi A; Ram MR; Velu V; Larsson M; Shankar EM
    Cell Immunol; 2017 Mar; 313():1-9. PubMed ID: 28104239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease.
    Barathan M; Mohamed R; Saeidi A; Vadivelu J; Chang LY; Gopal K; Ram MR; Ansari AW; Kamarulzaman A; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2015 May; 45(5):466-74. PubMed ID: 25721991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.
    Owusu Sekyere S; Suneetha PV; Kraft AR; Zhang S; Dietz J; Sarrazin C; Manns MP; Schlaphoff V; Cornberg M; Wedemeyer H
    J Hepatol; 2015 Jan; 62(1):31-40. PubMed ID: 25131771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
    Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
    J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
    Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
    Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients.
    Feng G; Zhang JY; Zeng QL; Jin L; Fu J; Yang B; Sun Y; Jiang T; Xu X; Zhang Z; Yuan J; Wu L; Wang FS
    Mol Cells; 2013 Oct; 36(4):362-7. PubMed ID: 24170093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
    Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
    J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
    Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
    J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
    Llorens-Revull M; Costafreda MI; Rico A; Guerrero-Murillo M; Soria ME; Píriz-Ruzo S; Vargas-Accarino E; Gabriel-Medina P; Rodríguez-Frías F; Riveiro-Barciela M; Perales C; Quer J; Sauleda S; Esteban JI; Bes M
    PLoS One; 2021; 16(7):e0254243. PubMed ID: 34242330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
    Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
    Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
    MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
    Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
    Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
    Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.